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Abstract 
Multiple Sclerosis (MS) is a chronic inﬂammatory disease of the Central Nervous System (CNS). The presence of 
Oligoclonal Band (OCB) in Cerebrospinal Fluid (CSF) is an important diagnostic tool in MS. The main aim of 
this study was to determine SNPs and SNPs-SNPs interactions in the genomic TSAD (T-Cell Specific Adaptor 
Proteins) region which explain the difference between two MS conditions: OCB positive vs. OCB negative in 
sampled Norwegian patients. The data to this study was obtained from the MS Registry Ulleval University Hospital, 
Oslo, Norway. Of 899 patients, 802 were OCB positive and 97 OCB negative, each has 923 SNPs at speciﬁc 
position in their chromosome measure. The study incorporated two different statistical methods to our data analysis. 
First, we apply variable selection based on Lasso method, here we discuss Lasso for Logistic Regression Analysis 
and see interaction effect for the Lasso selected SNPs. In the second section, we analyze variable selection based 
on test of association. Here, we used Chi-Square and Fisher’s exact test of association to see association between 
the statuses of OCB to each SNP. We found out that the Chi-Square test of association selected 34 signiﬁcant 
SNPs and the association test for Fisher’s exact test selected 38 signiﬁcant SNPs at signiﬁcance level of 0.05. Then 
we used Boferroni and False Discovery Rate to statistically signiﬁcant SNPs for the multiple testing corrections. 
Finally, we looked for interaction effects to some selected SNPs from test of association and we have determined 
SNPs and SNP-SNP interactions which appear to have signiﬁcant associated to the OCB subpopulation of MS 
patients, based on our study of the Norwegian cohort. These are selected SNPs which have been selected by any 
of the methods that we used (various hypothesis testing and regressions). This is the SNPs that we think should be 
studied further and validated on a new dataset. Of particular importance are the seven SNP-SNP interactions which 
we found. It is the ﬁrst time a SNP-SNP study has been performed on these data, and the ﬁnding will be 
communicated to the Norwegian molecular biologists to be followed up. 
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Multiple sclerosis (MS), also known as disseminated sclerosis or encephalomyelitis disseminate, is an 
inﬂammatory disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, 
leading to demyelination and scarring as well as a broad spectrum of signs and symptoms (Coles et al, 2008)[1]. In 
patients with multiple sclerosis, myelin, the fatty tissue which protects nerve ﬁbers in the CNS, deteriorates leading 
to neurological problems and disorders of the CNS. 
Patients with multiple sclerosis suffer from a variety of symptoms, including visual problems, muscle 
weakness, difﬁculties with coordination and speech, fatigue, cognitive impairment, problems with balance, and 
pain. Multiple sclerosis is a debilitating disease which leads to impaired mobility and disability in most cases. It 
appears that multiple sclerosis is a modern day disease, but there has been mention of symptoms associated with 
the disease as far back as the 14th century. In 1947, the skeleton of St. Lidwina of Schiedam, which is a suburb of 
Rotterdam, Holland, was discovered during a reconstruction project. 
It appeared that Lidwina, who lived from 1380 to 1433 had a case of MS. The skeleton showed signs of 
muscular atrophy and paralysis of both legs. It was recorded that Lidwina suffered from difﬁculty walking and 
a ”hanging lip” which could possibly be indicative of facial paralysis. It was also recorded that in the last 15 years 
of her life, Lidwina had large wounds on her body, difﬁculty swallowing, blindness, and other pains (Murray, 
2005)[2]. Disease onset usually occurs in young adults, and it is more common in women (Coles et al, 2008) [1]. 
MS was ﬁrst described in 1868 by Jean-Martin Charcot (Clanet, 2008)[3]. MS affects the ability of nerve cells in 
the brain and spinal cord to communicate with each other effectively. Nerve cells communicate by sending 
electrical signals called action potentials down long ﬁbers called axons, which are contained within an insulating 
substance called myelin. In MS, the body own immune system attacks and damages the myelin. When myelin is 
lost, the axons can no longer effectively conduct signals (Coles et al, 2002)[4]. The name multiple sclerosis refers 
to scars (sclerae-better known as plaques or lesions) particularly in the white matter of the brain and spinal cord, 
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which is mainly composed of myelin (Clanet, 2008)[3]. Although much is known about the mechanisms involved 
in the disease process, the cause remains unknown. Theories include genetics or infections. 
Different environmental risk factors have also been found (Coles et al, 2002)[4] and Munger et al, 2007)[5]. 
Almost any neurological symptom can appear with the disease, and the disease often progresses to physical and 
cognitive disability (Coles et al, 2002)[4]. MS takes several forms, with new symptoms occurring either in discrete 
attacks (relapsing forms) or accumulating over time (progressive forms) (Reingold et al, 1996)[6]. Between attacks, 
symptoms may go away completely, but permanent neurological deﬁcits often occur, especially as the disease 
advances (Reingold et al, 1996)[6]. There is no known cure for multiple sclerosis. Treatments attempt to return 
function after an attack, prevent new attacks, and prevent disability (Coles et al, 2002)[4]. 
MS medications can have adverse effects or be poorly tolerated, and many people pursue alternative 
treatments, despite the lack of supporting scientiﬁc study. The prognosis is difﬁcult to predict; it depends on the 
subtype of the disease, the individual’s disease characteristics, the initial symptoms and the degree of disability 
the person experiences as time advances (Weinshenker, 1994)[7]. Life expectancy of people with MS is 5 to 10 
years lower than that of the unaffected population (Coles et al, 2008)[1]. The clinical manifestations typically ﬁrst 
develop in young adults as acute relapses, and then evolve into a gradually progressive course with permanent 
disability after 10-15 years. It is a complex disease inﬂuenced by many factors rather than driven by a single cause. 
Research into the genetics of MS therefore involves the search for genes that contribute to susceptibility and/or to 
the severity and other aspects of the disease. More recently, genetic research has extended into the study of 
inherited variations in response to treatment (pharmacogenetics). For many years it has been evident that close 
family members of a person with MS have a higher risk of having the disease, and the closer they are genetically, 
the higher the risk. Unrelated family members (such as husband or wife) show no increased risk but the children 
of marriages where both parents have MS have a particularly high risk. A large study of people with MS who were 
adopted under the age of one year clearly showed that risk is largely due to genetic factors rather than the 
environment MSIF (2007)[8]. Relatives of patients with MS are at increased risk for the disease and several lines 
of evidence indicate that MS has a genetic component. However, the genetic basis of MS is complex (i.e., multiple 
genes contribute cumulatively to the risk of MS and disease behavior) and is heterogeneous (i.e., the genes and 
alleles involved probably differ from patient-to-patient). The prevalence of MS is approximately 1/1000, affecting 
approximately 400, 000 people in the US and 2 million worldwide (Marrie, 2004)[9]. It is the most common non-
traumatic cause of neurologic disability in young adults. Onset typically is between the ages of 20 and 40 years, 
and women are affected more frequently than men (or approximately 3:2). The presence of OCB in CSF is an 
important diagnostic tool in MS and is thought to reﬂect a local B-cell response of unknown speciﬁcity and 
signiﬁcance (Poser et al, 1983, McDonald et al, 2001 and Polman et al, 2010)[10]. 
The single most consistent laboratory Abnormality in patients with MS exclusive of magnetic resonance 
imaging is increased oligoclonal immunoglobuns in cerebrospinal ﬂuid (Paty, 1988)[11]. In patients with a single 
demyelinating episode, detection of intrathecal immunoglobunin synthesis may predict progression to MS (Paolino, 
1996)[12], and oligoclonal band (OCBs) in CSF during the early phase of disease are associated with a worse 
outcome (Amato, 2000)[13]. Up to 95% of MS patients in Northern Europe have OCB in the CSF, but this frequency 
varies de- pending on laboratory routines, study populations and was recently also related to latitude (Link and 
Huang, 2006 and Andersson et al, 1994)[14]. (Joseph, 2008)[15] in his result to case control study on 100 MS patients 
sampled from southwest England and south Wales, indicated that an approximate minimum 3% of patients with 
MS were OCB negative. They were signiﬁcantly more likely to exhibit neurological or systemic clinical features 
a typical of MS (headaches, neuropsychiatric features and skin changes). Non-speciﬁc MRI (Magneti Resonance 
Imaging), blood and (other) CSF abnormalities were also more common, emphasizing the need for continued 
diagnostic vigilance, although the incautious application of McDonald diagnostic criteria in OCB negative cases 
renders categorization as deﬁnite, MS more likely. 
 
1.2 Statement of the Problem 
Multiple sclerosis is an autoimmune disease which has a high and growing incidence in many parts of the world. 
It is a chronic or relapsing disease, and incurable. Two and half million people worldwide are affected by MS 
(Kerstin, 2009)[16]. 
Biologists believe that inheritable diseases like cancer or multiple sclerosis can be recognized or predicted by 
looking to SNPs (or Single nucleotide polymorphisms) of people which is single base positions in the human DNA 
which are mutated (polymorphic), that is different in some individuals with respect to the whole population. Ideally, 
a set of SNPs can be the cause of the disease. There is, indeed, a genetic susceptibility to multiple sclerosis which 
originated in Scandinavia (high prevalence occurred), and the susceptibility alleles have been transmitted to other 
races by gene ﬂow (Gunderson et al, 2007)[17]. So, in this study we are aimed to look for Statistical analysis of the 
Tsad interactome in multiple sclerosis:  
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 Can we use some of the SNPs which are associated to OCB conditions in genomic TSAD region, so that 
they will allow a classiﬁcation of future patients in the OCB conditions of MS? 
 Do SNPs in the genomic TSAD region have signiﬁcant association with the OCB condition? 
 Can we ﬁnd interactions of SNPs in the genomic TSAD region which are associated to the OCB condition, 
and therefore describe ﬁrst elements of the biological mechanisms of the OCB condition in MS? 
 
1.3 Objectives of the Study 
The general objective of this study is to identify SNPs and SNPs-SNPs interactions in the genomic TSAD region 
which explain the difference between two MS conditions: OCB positive vs. OCB negative. 
Speciﬁc Objectives the Study 
 To apply logistic regression and ﬁt the model with lasso penalty to determine SNPs in the genomic TSAD 
region which are associated to the status of OCB so that they will allow a classiﬁcation of future patients in 
the OCB conditions of MS. 
 To investigate genetic factors of the genomic TSAD region which important for the disease condition of OCB 
in Multiple Sclerosis with different kind of statistical hypothesis (Fisher Exact and Chi-Square test of 
association). 
 To assess which SNPs in the TSAD region have signiﬁcant association with the OCB condition, using multiple 
testing correction method: Bonferroni and False Discovery Rate. 
 To identify SNP-SNP interactions in the genomic TSAD region which are associated to the OCB condition, 
and therefore describe ﬁrst elements of the biological mechanisms of the OCB condition in MS. 
 
2. Methodology 
2.1 Description of the Data 
The data for this study was secondary data collected from two Norwegian samples: The Oslo MS DNA Bio Bank 
and The Norwegian MS Registry and Bio Bank held in Bergen. In the Oslo MS DNA Bio Bank the majority of 
patients are recruited by the neurologists at Oslo University Hospital, Ulleval with the remainder coming from 
local MS societies and other neurological departments are serving the suburban Oslo areas. Samples in the 
Norwegian MS Registry and Bio bank were recruited from all other parts of Norway. This collection started in 
2007, and currently includes approximately 1/5 of the prevalent MS patients in Norway. 
 
2.2 Description of Variables Considered under the Study 
In this study, we categorized the status of a total of 899 MS patient into two groups. Of these 802 persons are OCB 
positive and 97 persons OCB negative. OCB are proteins found in the spinal ﬂuid of MS patients. They are called 
oligoclonal bands, because they appear in the part of the electrophoresis of the spinal ﬂuid where the gamma 
globulins are found. It is thought to be produced by single clones of B-cells located within the CNS of the MS 
patients. The origin of the OCB is not understood, but they are viewed as quite speciﬁc for MS, although not all 
MS patients do have these bands. It is important to try to ﬁnd a genetic signature of the OCB positive versus OCB 
negative MS patients. This will allow a better understanding of the diseases and also a possibility to predict the 
long term prognoses. For each person, we have used 923 SNPs (or Single Nucleotide Polymorphism) in 923 
speciﬁc positions of their DNA. These 923 SNPs have been chosen because they are located in, or around, genes 
on the DNA who have to do with an important protein, called T cell speciﬁc adapter protein (TSAd), which is 
believed to have a very important role in development of MS. This means that these SNPs have some good chances 
to be relevant in the distinction between OCB and not OCB, as they reside on genes which biologists believe are 
important in MS. T cells play a crucial role in our defense against infection and cancer, but these cells are also 
dangerous sometimes, as they can start to react against the body they are supposed to defend, leading to 
autoimmune disease, like MS. This probably happens because these cells are triggered in some way. We do not 
know exactly how and why. The last 10 years many research groups worldwide have therefore focused primarily 
on elucidating molecular mechanisms for control of T cell activation, and in particular the role of T-cell speciﬁc 
adapter protein (TSAd) in this process. One group is led by Professor Anne Spurkland, and she has selected for us 
these 923 SNPs. 
The importance of TSAd is described in many papers. We cite here the ones of the group of Professor 
Spurkland. They have found that TSAd modulates early signaling events in T cells (Kolltveit et al, 2008)[18]. 
Spurkland has found that a certain gene participating to the production of TSAd, is associated with increased 
susceptibility to MS and juvenile arthritis (Lorentzen et al, 2008)[19]. Genetically determined variation in the 
expression level of TSAd may provide a mechanism for how TSAd contribute to genetic susceptibility to 
autoimmune disease. Each person has 923 SNP (or Single Nucleotide Polymorphism) at speciﬁc position in their 
chromosome measure. Each patient has age at onset 33.7 years, old age of diagnosis 48.5 years clinical course and 
patients with primary progressive symptoms: 13%. 
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2.2.1 The Response Variable of the Study 
The outcome of interest in this study is the status of OCB, where OCB is categorized into OCB positive and OCB 
negative i.e., the outcome is categorical response with two categories. Hence, the response variable for the ith 
person is represented by the random variable Yi with two possible values coded as 1 for the success OCB ”positive” 
and ”0” otherwise Mathematically, we write this as:  
Yi= ,   	
 	 
   
,                                           	

,                                                                      (1)     
2.2.2 Independent Variables of the Study 
Each person in this study has 923 SNPs (or Single Nucleotide Polymorphism) at speciﬁc position in their 
chromosome measure. The layout for these 923 SNPs (explanatory variables) and their coding is given below. The 
unavailable data value is coded as ”NA” and each SNP has three allele sequence in their DNA. That is AA TA or 
AT and TT. For the sake of analysis it was coded as 0 for AA 1 for AT or TA and 2 for TT. Therefore, the 
summary in the following table 1 shows the coding of this predictor variable. 
Table 1: Independent Variables and their coding 
Variables  Coding 
SNP1  
SNP2 
  SNP3 
   ⋮ 
SPk 
(k≤923) 
AA = 0, AT,TA = 1, TT = 2 AA = 
0, AT,TA = 1, TT = 2 AA = 0, 
AT,TA = 1, TT = 2 
 ⋮ 
AA = 0, AT,TA = 1, TT = 2 
 
2.3 Method of Data Analysis 
2.3.1 Fitting the Logistic Regression Model to Data 
As in multiple regression analysis, there are two important stages in the analysis of data. First, estimation of the 
parameters in the model must be obtained. Second, some determination must be made of how well the model 
actually ﬁts the observed data. In multiple regression analysis, the parameter estimates are obtained using the least-
squares principle and assessment of ﬁt is based on signiﬁcance tests for the regression coefﬁcients as well as on 
interpreting the multiple correlation coefﬁcients. But in LRA, the parameters that must be estimated from the 
available data are the constant,, and the logistic regression coefﬁcients, j. Because of the nature of the model, 
estimation is based on the maximum likelihood principle rather than on the least-squares principle. Maximum 
likelihood estimation (MLE) is the standard method of estimating the unknown parameters in a logistic regression 
model. This method yields values for the unknown parameters which maximize the probability of obtaining the 
observed response values. The likelihood function expresses the probability of the observed response values as a 
function of the unknown parameters. In the context of logistic regression analysis, maximum likelihood estimation 
(MLE) involves the following. First, we deﬁne the likelihood, L(parameter|data), of the sample data as the product, 
across all sampled cases, of the probabilities for success or for failure: 
              L(parameter|data)  = ∏ (, | , ⋯  ")$%     
                                            =∏ &' () * ∑ ,-  -"-./ () * ∑ ,-  -"-. 0
 ' / () * ∑ ,-  -"-. 0
12$%            (1) 
Note that Y is the 0/1 outcome for the ith case and, Xi1,⋯,Xip are the values of the predictor variables for 
the ith case based on a sample of n observations. The use of Yi and 1-Yi as exponents in the equation above 
includes in the likelihood the appropriate probability term dependent upon whether Yi =1 or Yi =0. Using the 
methods of calculus, a set of values for and the can be calculated that maximize L(parameter|data) and these 
resulting values are known as maximum likelihood estimates (MLE’s). This maximization process is somewhat 
more complicated than the corresponding minimization procedure in multiple regression analysis for ﬁnding least-
square estimates. However, the general approach involves establishing initial guesses for the unknown parameters 
and then continuously adjusting these estimates until the maximum value of L(parameter|data) is found. This 
iterative solution procedure is available in statistical packages. The usefulness of the model as a whole can be 
assessed by testing the hypothesis that, simultaneously, all of the partial logistic regression coefﬁcients are 0; i.e., 
H: ,j = 0 for all j. In effect, we can compare the general model given above with the restricted model ln( 313) =) . 
This test, that is equivalent to testing the signiﬁcance of the multiple R in multiple regression analysis, is based on 
a chi-squared statistic (R software calculates the value of ”Chi-Square”). Finally, different logistic regression 
coefﬁcients models ﬁtted to the same set of data can be compared statistically in a simple manner if the models 
are hierarchical. The hierarchy principle requires that the model with the larger number of predictors include 
among its predictors all of the predictors from the simpler model. Given this condition, the difference in model 
chi-squared values is (approximately) distributed as chi-squared with degrees of freedom equal to the difference 
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in degrees of freedom for the models. In effect, this procedure tests a conditional null hypothesis. If the models 
are speciﬁed, R software calculates Chi-square value for each model and this can be used to test whether or not 
the additional predictors result in signiﬁcantly better ﬁt of the model to the data. 
2.3.2 Variable Selection for Logistic Regression: Lasso (Least absolute shrinkage and selection operator) 
A statistical model is a simpliﬁcation of reality (Agresti, 2007)[20]. At the initial stage of modeling, a large number 
of candidate predictors are considered to minimize possible modeling biases (Fan and Li, 2006)[21]. However, in 
most cases, not all the predictors have signiﬁcant effects on the response variable. In statistics, a result from certain 
hypothesis testing is called statistically signiﬁcant if it is unlikely to have occurred by chance. A simpler model 
that contains only the important predictors is preferred because it is easy to explain. Parsimony is especially 
important for high dimension data. The parsimony means that the simplest plausible model with the fewest possible 
number of predictors is desired. Variable selection plays an important role in regression analysis and is intended 
to select the best subset of predictors. There are typically two competing goals in statistical modeling: The model 
should be complex enough to ﬁt the data well, and also should be simple to interpret (Agresti, 2007)[20]. In linear 
regression, parameter estimation by the ordinary least square (OLS) method is unbiased. However the estimates 
may have large variance in some cases, the occurrence of multi-co linearity for instance is one case. With slight 
sacriﬁce of bias, ridge regression tends to improve the prediction accuracy by shrinking some coefﬁcients. But 
ridge regression will not shrink values of any coefﬁcients to exact 0, and the ﬁtted model might be too complex to 
interpret. In 1996, Tibshirani introduced a different shrinkage method, called the Lasso (least absolute shrinkage 
and selection operator). This method shrinks values of some coefﬁcients to 0 by a constraint on the sum of absolute 
values of regression coefﬁcients, so Lasso can serve as a tool for variable selection. The Lasso is a shrinkage 
method like ridge regression, with subtle but important differences. Like ridge regression, penalizing the absolute 
values of the coefﬁcients introduces shrinkage towards zero. However, unlike ridge regression, some of the 
coefﬁcients are shrunken all the way to zero; such solutions, with multiple values that are identically zero, are said 
to be sparse. The penalty thereby performs a sort of continuous variable selection. The resulting estimator was thus 
named the Lasso, for ”Least Absolute Shrinkage and Selection Operator” and deﬁned by: ,456778 = 69:;$,  <∑ => − , − ∑ @-,--% ABC% D                                                      (2) 
Subject to ∑ E,-E-%  ≤ F Where, t ≥ 0 is a tuning parameter which controls the amount of shrinkage that is applied 
to the estimates and for all t  , =  >H .  Just as in ridge regression, we can re-parameterize the constant ,0 by 
standardizing the predictors; the solution for ,40 is >H , and thereafter we ﬁt a model without an intercept by 
assuming >H  = 0 and omitting , 0 without loss of generality. Computing the Lasso solution is a quadratic 
programming problem, although efﬁcient algorithms are available for computing the entire path of solutions as I 
is varied, with the same computational cost as for ridge regression. Because of the nature of the constraint, making 
t sufﬁciently small will cause some of the coefﬁcients to be exactly zero. Thus the Lasso does a kind of continuous 
subset selection. If t is chosen larger than  
t0 = ∑ E,-E-%  ≤ F  (where ,4j = ,4jls, the least square estimates), then the Lasso estimates are the ,4jls. (Hui et al, 
2007)[22] develop versions of AIC and BIC for Lasso that can be used to ﬁnd an ”optimal” value or  or equivalently 
t. They suggested using BIC to ﬁnd the ”optimal” Lasso model when sparsity of the model is of primary concern. 
Lars, least angle regression (Efron et al, 2004)[23] provides a clever and hence very efﬁcient way of computing the 
complete Lasso sequence of solutions as s is varied from 0 to inﬁnity. In fact, (Hui et al, 2007)[22] show that it is 
possible to ﬁnd the optimal Lasso ﬁt with the computational effort equivalent to obtaining a single least squares ﬁt. 
Thus, the lasso has the potential to revolutionize variable selection. It employs an L1-type penalty on the regression 
coefﬁcients which tends to produce sparse models, and thus is often used as a variable selection tool as in 
(Tibshirani, 1997 and Osborne, et al, 2000)[24]. (Knight and Fu, 2000)[25] studied the asymptotic properties of Lasso-
type estimators. They showed that under appropriate conditions, the Lasso estimators are consistent for estimating 
the regression coefﬁcients, and the limit distribution of the Lasso estimators can have positive probability mass at 
0 when the true value of the parameter is 0. It has been demonstrated in (Tibshirani, 1996)[26] that the Lasso is more 
stable and accurate than traditional variable selection methods such as best subset selection. For Multiple 
Regression Analysis, lasso penalty give as: 
 ,4 =69:;$, J∑ (> −  K)BC% L + I ∑ E,-E-%                          (3) 
Where, M is the Lasso penalizing parameter. For logistic regression, Lasso modiﬁes the traditional parameter 
estimation method, maximum log likelihood, by adding the L1 norm of the parameters to the negative log 
likelihood function, so it turns a maximization problem into a minimization one. To solve this problem, we ﬁrst 
need to give the value for the parameter of the L1 norm, called tuning parameter. Since the tuning parameter affects 
the coefﬁcients estimation and variable selection, we want to ﬁnd the optimal value for the tuning parameter to get 
the most accurate coefﬁcient estimation and best subset of predictors in the L1 regularized regression model. There 
are two popular methods to select the optimal value of the tuning parameter that results in a best subset of predictors, 
Bayesian information criterion (BIC) and cross validation (CV). Therefore, best subsets of predictors are selected 
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after standardizing the predictor variable by applying BIC or k-fold cross-validation (CV) (Tibshirani1, 996)[26]. 
Then, the package glmnet gives an optimum tuning parameter or N for CV. In case of logistic regression with lasso, 
the model can be expressed as:  
 ,4 =69:;6@,  JO(,) − I ∑ E,-E-% L                                                                                 (4) ,4 =69:;6@,,  <P>(, +  ,K@)  −  O8:( + (, *  ,K@ )R  −  I ∑ E,-E-% D                     (5) 
Where M is positive integer that determines the amount of shrinkage. As with the Lasso, we typically do not 
penalize the intercept term, and standardize the predictors for the penalty to be meaningful. (Efron, 2004)[23] 
proposed the Least Angle Regression (the Lars), and showed that there is a close connection between the lars, the 
Lasso, and another model selection procedure called the Forward Stage wise regression. Each of these procedures 
involves a tuning parameter that is chosen to minimize the prediction error. 
2.3.3 Selection of Tuning Parameter: Cross Validation 
Cross validation is a popular method for estimating the prediction error and comparing different models. Typically, 
the dataset partition into two parts: the training data and the testing data. In k-fold cross validation, the dataset will 
be randomly split into k mutually exclusive subsets of approximately equal size. Among the k subsets, one subset 
is retained as validation data for testing the model, and the remaining k-1 subsets are used as training data to ﬁt the 
model. The cross validation process will be repeated k times, and each of the subsets is used exactly once as 
validation data. Different values of the tuning parameter could result in different ﬁtted model using the same 
training data. The optimal model is the one that has the minimum cross-validated errors, and the corresponding 
value of the tuning parameter for the optimal model is preferred (Jerome et al, 2008)[27]. 
2.3.4 Lasso for Logistic Regression to See Interaction Effect 
Testing for interactions after identifying main effects or marginal predictors is the next step. This strategy is 
prompted by the number of interactions possible. With p predictors, we have: =BA Two-way interactions but, with 
hundreds of thousands of SNPs, it is impossible even to examine all two-way interactions (Tong, 2009)[28]. To 
evaluate the performance of Lasso penalized regression in association testing, we focus on underdetermined 
problems where the number of predictors’ p far exceeds the number of observations n. Here for two-way case, the 
model is: Which involve both marginal and two way interactions. 
logS 1T = U + ∑ @-,--% + ∑ ∑ @V@OWVOO%V%                                                                        (6) 
 
2.4 Statistical Hypotheses Testing 
Hypothesis testing is concerned with using observed data to make decisions regarding properties of (i.e., 
hypotheses for) the unknown data generating distribution. In any testing problem, two types of errors can be 
committed. A Type I error, or false positive, is committed by rejecting a true null hypothesis. A Type II error, or 
false negative, is committed by failing to reject a false null hypothesis. Ideally, one would like to simultaneously 
minimize both the number of Type I errors and the number of Type II errors. Unfortunately, this is not feasible 
and one seeks a trade-off between the two types of errors. This trade-off typically involves the minimization of 
Type II errors, i.e., the maximization of power, subject to a Type I error constraint. As in the case of single 
hypothesis testing, one can report the results of a multiple testing procedure in terms of the following quantities: 
rejection regions for the test statistics, conﬁdence regions for the parameters of interest, and adjusted p-values. 
Adjusted p-values, for the test of multiple hypotheses, are deﬁned as straightforward extensions of unadjusted p-
values, for the test of individual hypotheses: the adjusted p-value for a particular null hypothesis is the smallest 
nominal Type I error level (for the multiple test of all hypotheses) at which one would reject this null hypothesis. 
The smaller the adjusted p-values indicates, the stronger the evidence against the corresponding null hypothesis 
(Sandrine et al, 2008)[29]. 
2.4.1 Chi-Square Test of Independence 
The Chi-Square test may be used both as a test of goodness-of-ﬁt (comparing frequencies of one categorical 
variable to theoretical expectations) and as a test of independence. The underlying arithmetic of the test is the same 
to test of goodness-of-ﬁt but the only difference is the way the expected values are calculated. However, goodness-
of-ﬁt tests and tests of independence are used for quite different experimental designs and test different null 
hypotheses. The Chi-Squared test of independence is used when we have two categorical variables, each with two 
or more possible values. 
2.4.2 Fisher’s Exact Test 
This test is used when we have two nominal variables. A data set like this is often called an (R x C table), where 
R is the number of rows and C is the number of columns. Fisher’s exact test is more accurate than the Chi-Squared 
test of independence when the expected numbers are small. The most common use of Fisher’s exact test is for (2 
x 2 tables). But for our case we use (2 x 3 tables) for each SNPs. Fisher’s Exact test assumes that the row and 
column totals are ﬁxed. In the much more common design, the row totals and/or column totals are free to vary. In 
this case, the Fisher’s Exact test is not, strictly speaking, exact. It is still considered to be more accurate than the 
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chi-square and we should feel comfortable using it for any test of independence with small numbers. 
2.4.3 The Problem of Multiple Testing Correction 
Any time you reject the null hypothesis because a p-value is less than your critical value. It is possible that you are 
wrong; the null hypothesis might really be true, and your signiﬁcant result might be due to chance. A P-value of 
0.05 means that there is a 5% chance of getting your observed result, if the null hypothesis were true. This problem, 
that when you do multiple statistical tests, some fraction will be false positives, has received increasing attention 
in the last few years. This is important for such techniques as the use of microarrays, which make it possible to 
measure RNA quantities for tens of thousands of genes at once (Mcdonald, 2001)[30]. Controlling for multiple 
testing to accurately estimate signiﬁcance thresholds is a very important aspect of studies involving many genetic 
markers, particularly GWA studies. The type I error, also called the signiﬁcance level or false-positive rate, is the 
probability of rejecting the null hypothesis when it is true. The signiﬁcance level indicates the proportion of false 
positives that an investigator is willing to tolerate in his or her study. The family-wise error rate (FWER) is the 
probability of making one or more type I errors in a set of tests. Lower FWERs restrict the proportion of false 
positives at the expense of reducing the power to detect association when it truly exists. It is then important to keep 
track of the number of statistical comparisons performed and correct the individual SNP-based signiﬁcance 
thresholds for multiple testing to maintain the overall FWER (Zondervan et al, 2007)[31]. In order to choose an 
appropriate multiple testing methods, it is critical to select the deﬁnition of correct decisions. The following sub-
sections introduce the common multiple testing correction methods. 
2.4.4 Bonferroni Correction 
The classical approach to the multiple comparison problem is to control family- wise error rate (Bland et al, 
1995)[32]. Instead of setting p-value for signiﬁcance, or, ) to 0.05, a lower  ) is used. If the hypothesis is true for 
all tests, the probability of getting one result that is signiﬁcant at this new lower, level is 0.05. In other words, if 
the null hypotheses are true, the probability that the family of tests includes one or more false positive due to 
chance is 0.05. The most common way and simplest of the p-value-based procedures to control the family-wise 
error rate is the well-known Bonferroni procedure. The basic procedure is: The signiﬁcance level ()) for an 
individual test is found by dividing the family-wise error rate (usually 0.05) by the number of tests. If we are doing 
100 statistical tests, the ) level for an individual test would be X.XZ[XX   = 0.0005, and only individual tests with p-value 
< 0.0005 would be considered signiﬁcant. The Boferroni correction assumes that the tests are independent of each 
other, and the method has good job of controlling family-wise error rate for multiple, independent comparisons; 
but important issue with Bonferroni correction is deciding what a ”family” of statistical test is. However there is 
no ﬁrm rule on this; we have to use our judgement, based on just how bad a false positive would be. 
2.4.5 False Discovery Rate 
A different approach to multiple testing does not try to control the family-wise error rate, (the probability can be 
computed under the assumption that all hypotheses are simultaneously true), but focuses instead on the proportion 
of falsely signiﬁcant genes. As we will see, this approach has a strong practical appeal and it is an alternative 
approach to control family wise error rate. It is the proportion of ”discoveries” (signiﬁcant results) that are actually 
false positive. For the example, suppose we are using microarray to compare expression levels of 100, 000 genes 
between liver tumors and normal liver cells. We are going to do additional experiments on any genes that show a 
signiﬁcant difference between the normal and tumor cells, and we are willing to accept up to 10% of the genes 
with signiﬁcant results being false positive; we ﬁnd out they are false positives when we do the follow-ups 
experiment. In this case, we would set our false discovery rate to 10%. A good technique for controlling false 
discovery rate was brieﬂy mentioned by (Simes, 1986)[29] and developed in detail by (Benjamini and Hochberg, 
1995)[33]. 
Table 2: Possible outcomes of individual tests 
 H0Accepted H0Rejected Total 
H0 True nT ;A nT ;R nT 
H0 False nF ;A nF ;R n-nT ornF 
Total n-nR nR N 
In the above table: 
 n is the total number hypotheses tested 
 \] is the number of true null hypotheses 
 n - \] or \^ is the number of false null hypotheses or true alternative hypotheses 
 \] ; R is the number of false-positive tests (Type I error) (also called ”false discoveries”) 
 \^ ;A is the number of false negatives (Type II error) 
 \] ;A is the number of true negatives 
 \] ; R is the number of true positives (also called ”true discoveries”) 
 \_ is the number of rejected null hypotheses (also called ”discoveries”) 
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In n hypothesis tests of which \] are true null hypotheses, \_ is an observable random variable and \^; R, \^ ;A, \];A and \];R are unobservable random variables. The type I error rate is E[\];R]/\] , the type-II error rate is 
E[\^ ;A]/ \^, family-wise error rate is Pr(\];R ≥ 1) and the power is 1 - E[\] ;A]/ \^ . Here our focus is on the 
false discovery rate which is deﬁned as: FDR = E(\];R |\_) that is, the expected proportion of genes that are 
incorrectly called signiﬁcant, among the R genes that are called signiﬁcant. The expectation is taken over the 
population from which the data are generated. If the hypotheses are independent, (Benjamini and Hochberg, 
1995)[33] show that regardless of how many null hypotheses are true and regardless of the distribution of the p-
values when the null hypothesis is false, this procedure has the property: 
FDR ≤  $K$ ) ≤  ) (7) 
 
Algorithm 1 Benjamini-Hochberg (BH) Method: 
1. Fix the false discovery rate   and [` ≤  a` ≤, ⋯ ≤, b` denote the ordered p-values 
2. Deﬁne, L = maxj : pj < ∙  db 
3. Reject all hypotheses H0j for which d` ≤  e`  ; BH rejection threshold. 
That is put the individual p-values in order, from smallest to largest. The smallest p-value has a rank of i=1, the 
next has i=2, etc. Then compare each individual p-value to (
fb)Q, where, m is the total number of tests and Q is the 
chosen false discovery rate. The largest p-value that has p < (
fb)Q, is signiﬁcant, and all p-values smaller than it are 
also signiﬁcant. 
 
3. Results and Discussion 
3.1 Results 
The main objective of our work is to determine SNPs and SNPs-SNPs interactions in the genomic TSAD region 
which explain the difference between two MS conditions: OCB positive vs. OCB negative using the data from the 
Oslo MS DNA Bio Bank and The Norwegian MS Registry and Bio Bank. Accordingly, the analysis is carried out 
in two different approaches or variable selection methods: Variable Selection Based on Lasso applied to Binary 
Logistic Regression analysis and Variable Selection Based on Test of Association. 
 
3.2 Analysis I: Variable Selection Based on Lasso Method 
Variable selection plays an important role in regression analysis and is intended to select the best subset of 
predictors. Therefore, here we use the Lasso (Least absolute shrinkage and selection operator) which is a recent 
method of variable selection which applied when the number of samples is relatively smaller than the number 
parameters (variables). The Lasso method shrinks values of some coefﬁcients to 0 by a constraint on the sum of 
absolute values of regression coefﬁcients (penalty), so the Lasso can serve as a tool for variable selection. Such 
solutions, with multiple values that are identically zero, are said to be sparse. The penalty thereby performs a sort 
of continuous variable selection and the resulting estimator was thus named the Lasso, for Least Absolute 
Shrinkage and Selection Operator. In the following section, we apply the Lasso for Binary Logistic Regression 
analysis and we want to see interaction effects to some selected SNPs. 
 
3.3 Lasso for Logistic Regression Analysis 
Here we apply the Lasso variable selection to binary logistic regression on 923 SNPs. We run Lasso for 120 times, 
because it selects different random folds, each at different times. Then, Lasso method selects four SNPs after the 
optimum lambda 
 (i.e., lambda is obtained by subtracting one standard deviation from lambda.min) with ten and ﬁve-fold cross 
validation with glmnet package in R. These are most frequently selected SNPs which are the one which we selected 
in the end (See the Lasso Output for 923 SNPs at Appendix Section). Finally, we ﬁtted the model to our dataset 
which contains those selected SNPs by our method (see Equation 11). The Table 3 shows the four Lasso selected 
SNPs with the corresponding regression coefﬁcients and chromosome positions. Then we plot the corresponding 
cross validation curve to our dataset (See Figure 3). 
Log(
3g13g) = 0.00098∗NA + 0.08∗NA- 0.0261∗TEK-0.0894∗EGFR      (8) 
where, 3g is a conditional probability of the form P(Y=OCB|SNP1;⋯;SNP923). That is, it is assumed that success 
or Y=OCB is more or less likely depending on combinations of values of the SNPs or predictor variables. 
3.3.1 Interaction Effect for the Lasso Selected SNPs 
In this section, we study interaction effects of the ten variables. Four SNPs which are selected by Lasso (See Table 
3) and six interactions obtained by combination of these four SNPs which we selected by Lasso method with 
Logistic Regression Analysis on 923 SNPs. Then we have run Lasso to Logistic Regression Analysis for these 10 
variables. So, we found out that none of the interaction variables are selected (See the Lasso Output for 10 Variables 
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at Appendix Section). 
Table 3: The Lasso Selected SNPs 
S.no SNPs Chr Coeff 
1 rs706862A 6 0.0296 
2 rs4245566A 7 -0.1004 
3 rs2002680A 11 -0.0294 
4 rs11230645G 11 -0.0982 
 
 
Figure 3: CV for Lasso Logistic Regression Analysis 
 
3.4 Analysis II: Variable Selection Based on Test of Association 
In this section, we use different approach to select variables. First section identiﬁes an important variable by using 
test of associations. Here, we used Chi-Square and Fisher’s exact test of association. In the second section, we 
perform multiple independent hypotheses, that is we need to do some multiple testing corrections to control family 
wise error rate or Type I error rate for multiple hypotheses testing to multiple hypotheses from Fisher’s exact test 
of association. Here we use FDR and Bonferroni adjustment method for the 38 P-value (raw or unadjusted P-value) 
obtained by Fisher’s exact test. Finally, we identiﬁed the interaction effects to SNPs selected by Fisher’s Exact 
test. 
3.4.1 Fisher’s Exact and Chi-Square Test of Association 
We conducted 923 independent tests one for each SNP. We found out that the Chi-Square test of association 
selected 34 signiﬁcant SNPs and the association test for Fisher’s Exact test selected 38 signiﬁcant SNPs at 
signiﬁcance level of 0.05 (See Table 4 and Table 5 respectively). 
Table 4: SNPs Selected by Chi-Square Test 
no. SNPs Pv.chi no. SNPs Pv.chi no. SNPs Pv.chi 
1 rs4234103A 0.0045 13 rs692946A 0.0106 25 rs17092209G 0.0059 
2 rs13412634C 0.0411 14 rs1360773C 0.0062 26 rs633903C 0.0082 
3 rs11686987A 0.0494 15 rs1923332A 0.0062 27 rs6088659A 0.0003 
4 rs13419955A 0.0290 16 rs638203G 0.0042 28 rs491892G 0.0042 
5 rs824097G 0.0455 17 rs489451G 0.0038 29 rs6088646A 0.0489 
6 rs16843013A 0.0161 18 rs2756900G 0.0036 30 rs2145926G 0.0371 
7 rs17704348G 0.0353 19 rs1111782G 0.0417 31 rs6120757G 0.0489 
8 rs11238349A 0.0200 20 rs28599952A 0.0027 32 rs669102A 0.0134 
9 rs10280515G 0.0398 21 rs11616506A 0.0408 33 rs6088640G 0.0195 
10 rs4733037A 0.0260 22 rs16970646G 0.0169 34 rs3117638A 0.0152 
11 rs2292979G 0.0400 23 rs6088635A 0.0489    
12 rs11789885A 0.0314 24 rs4911163G 0.0489    
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Table 5: SNPs Selected by Fisher’s Exact Test 
no. SNPs Pv.ﬁsh no. SNPs Pv.ﬁsh no. SNPs Pv.ﬁsh 
1 rs4234103A 0.0009 14 rs692946A 0.0102 27 rs17092209G 0.0059 
2 rs13412634C 0.0308 15 rs1360773C 0.0055 28 rs633903C 0.0158 
3 rs11686987A 0.0420 16 rs1923332A 0.0065 29 rs6088659A 0.0004 
4 rs17261971A 0.0472 17 rs638203G 0.0047 30 rs491892G 0.0059 
5 rs13419955A 0.0237 18 rs489451G 0.0074 31 rs6088655A 0.0462 
6 rs824097G 0.0167 19 rs2756900G 0.0069 32 rs2145926G 0.0385 
7 rs16843013A 0.0469 20 rs1111782G 0.0384 33 rs6088646A 0.0440 
8 rs17704348G 0.0442 21 rs2002680A 0.0443 34 rs669102A 0.0152 
9 rs17586344G 0.0346 22 rs28599952A 0.0054 35 rs6120757G 0.0440 
10 rs11238349A 0.0270 23 rs11616506A 0.0359 36 rs3117638A 0.0248 
11 rs10280515G 0.0338 24 rs16970646G 0.0178 37 rs6088640G 0.0160 
12 rs4733037A 0.0288 25 rs6088635A 0.0440 38 rs11789885A 0.0391 
13 rs2292979G 0.0385 26 rs4911163G 0.0440    
3.4.2 Bonferroni and FDR for Multiple Testing Correction 
At FDR of 0.05, Benjamini and Hockberg (BH) adjustment for FDR shows all 38 SNPs are signiﬁcant that is, all 
38 raw P-value is below adjusted FDR. In similar manner, at family-wise-error rate of 0.05, the Bonferroni 
adjustment shows none of SNPs are signiﬁcant that is, none of the adjusted P-value is below unadjusted P-value 
(See Table 6). 
Table 6: Identiﬁed SNPs by Bonferroni and FDR 
S.no SNPs Pv.unadj Pv.adj.Bon Pv.adj.FDR 
1 rs6088659A 0.00040 0.01396 0.01396 
2 rs4234103A 0.00089 0.03141 0.17944 
3 rs638203G 0.00470 0.03141 0.20621 
4 rs28599952A 0.00540 0.03141 0.21023 
5 rs1360773C 0.00550 0.03141 0.22413 
6 rs491892G 0.00590 0.03141 0.22420 
7 rs17092209G 0.00590 0.03141 0.24613 
8 rs1923332A 0.00650 0.03141 0.26377 
9 rs2756900G 0.00690 0.03141 0.28271 
10 rs489451G 0.00740 0.03341 0.33406 
11 rs692946A 0.01020 0.03526 0.38788 
12 rs669102A 0.01520 0.04217 0.57860 
13 rs633903C 0.01580 0.04217 0.60217 
14 rs6088640G 0.01580 0.04217 0.60718 
15 rs16843013A 0.01670 0.04217 0.63467 
16 rs16970646G 0.01780 0.04217 0.67469 
17 rs13419955A 0.02370 0.04724 0.90147 
18 rs3117638A 0.02480 0.04724 0.94265 
19 rs11238349A 0.02700 0.04724 1.00000 
20 rs4733037A 0.02880 0.04724 1.00000 
21 rs13412634C 0.03080 0.04724 1.00000 
22 rs10280515G 0.03380 0.04724 1.00000 
23 rs17586344G 0.03460 0.04724 1.00000 
24 rs11616506A 0.03590 0.04724 1.00000 
25 rs1111782G 0.03840 0.04724 1.00000 
26 rs2292979G 0.03850 0.04724 1.00000 
27 rs2145926G 0.03850 0.04724 1.00000 
28 rs11789885A 0.03910 0.04724 1.00000 
29 rs11686987A 0.04200 0.04724 1.00000 
30 rs6088635A 0.04410 0.04724 1.00000 
31 rs4911163G 0.04410 0.04724 1.00000 
32 rs6120757G 0.04410 0.04724 1.00000 
33 rs6088646A 0.04410 0.04724 1.00000 
34 rs17704348G 0.04420 0.04724 1.00000 
35 rs2002680A 0.04430 0.04724 1.00000 
36 rs6088655A 0.04610 0.04724 1.00000 
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S.no SNPs Pv.unadj Pv.adj.Bon Pv.adj.FDR 
37 rs17054409G 0.04690 0.04724 1.00000 
38 rs17261971A 0.04720 0.04724 1.00000 
3.4.3 Interaction Effects of SNPs which found to have Signiﬁcant by Test of Association 
Here we study interaction effects of the 38 SNPs which are found to have signiﬁcant association. These are 703 
interactions obtained by combination and 38 SNPs which we found to have signiﬁcant association by Fisher’s 
Exact test. So, we have made variable selection among the 741 variables using Lasso method again with Binary 
Logistic Regression Analysis. We found out that seven SNP-SNP interactions are signiﬁcant by our method and 
none of main effects are signiﬁcant (See Lasso output for 741 variables at Appendix Section). These seven 
interactions variables are which listed below in Table 7. Then we plot the corresponding CV which is shown in 
Figure 4. Finally, we ﬁtted the model to our data which contains only seven interaction effects (See Equation 12 
below) 
Log(π ̂/(1-π ̂ )) =-0.020 * (a*b) -0.054  (c*d) -0.001                                                   (9) 
(f* g)-0.06  (f* b) -0.018  (c *e) -0.051  (c *e) -0.0067  (e *e)          
Where, a=MYO7B, b=EGFR, c=NA, d=ITK), f=FYN, g=NA and e=TEK and is a conditional probability of the 
form P(Y = OCB|SNP1,⋯,SNP923) or P(Y = OCB|SNP1,2,⋯,SNP922,923). That is, it is assumed that success or 
Y=OCB is more or less likely depending on combinations of values of the SNPs or combination of SNPs. 
Table 7: Interaction Effects of Selected SNPs by Lasso 
S.no SNPs(Symbol) Coeff 
1 rs4662738A(MY O7B)rs7780270C(EGFR) -0.0195 
2 rs17776723G(NA)  rs13190673A(ITK) -0.0544 
3 rs3752545C(FY N)  rs12678502A(NA) -0.0007 
4 rs1558542A(FY N)  rs7780270C(EGFR) -0.0600 
5 rs12678502A(NA)  rs7040866A(TEK) -0.0167 
6 rs12678502A(NA)  rs1923332A(TEK) -0.0514 
7 rs3739542C(TEK)  rs2208637A(TEK) -0.0057 
 
 
Figure 4: CV for Interaction Effects 
 
3.5 Discussion 
The results from analysis I with our proposed method (Variable Selection Based on Lasso Method) as a framework 
to determine important SNPs in the genomic TSAD region presented in this study identiﬁed four SNPs which 
appear to be associated to the Oligoclonal Bands(OCBs) subpopulation of multiple sclerosis patients (See Table 
3). We also tested  interaction effect by combining these four SNPs and ﬁnally the analysis showed none of the 
combinations (interactions) has an effects to Oligoclonal Bands (OCBs) subpopulation of multiple sclerosis 
patients. 
This ﬁndings suggests that these four SNPs independently determine the status of Oligoclonal Bands (OCBs) 
subpopulation of multiple sclerosis patients based on our study of the Norwegian cohort. Then, the ﬁnally model 
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contains four important SNPs which the method selected at the end (See Equation 8). The results from analysis 
II, shows that at 0.05 level of signiﬁcance, the Fisher Exact test identiﬁed 38 important SNPs from 923 SNPs in 
the genomic TSAD region that are associated with Oligoclonal Bands (OCBs) subpopulation of multiple sclerosis 
patients (See Table 5). The results from analysis II for Chi-Square test showed 34 important SNPs at 0.05 
signiﬁcances level (See Table 4). The results from analysis II for FDR at 0.05 signiﬁcant level of Benjamini and 
Hockberg (BH) procedure showed 38 SNPs are all important to determine Oligoclonal Bands (OCBs) 
subpopulation of multiple sclerosis patients (See Table 6). The similar result for Bonferroni correction or 
adjustment at family wise error rate of 0.05 showed none of SNPs are signiﬁcant. The ﬁnal results from analysis 
II for interaction effect to the variables obtained by combination among 38 SNPs selected previously from Fisher 
Exact test showed seven important SNP-SNP interactions which determine Oligoclonal Bands (OCBs) 
subpopulation of multiple sclerosis patients (See Table 7). Our study will be conﬁrmed with similar studies which 
identiﬁed potentially interesting logic expressions that represent SNP interactions and measures for quantifying 
the importance of these features for classiﬁcation in case control studies (Holger, 2008)[34]. Similar study indicated 
that many common diseases are inﬂuenced by interaction of certain genes and quadratic penalization not only 
correctly characterizes the inﬂuential genes along with their interaction structures but also yields additional beneﬁts 
in handling high dimensional, discrete factors with a binary response (Young, 2008)[35]. Other similar analysis 
indicated that penalizing the size of the coefﬁcients is a common strategy for robust modeling in regression 
classiﬁcation with high dimensional data and examined the properties of the Lasso constraints applied to the 
coefﬁcients in generalized linear models (GLM) to the speciﬁc application of modeling gene interactions (Young, 
2006)[36]. Results from (Yoav, 2002)[27] in their experiments aims to identify genes with altered expression in the 
livers of mice with very low cholesterol levels compared to inbred control mice. They examined the p-values 
obtained directly from the raw t-statistics with 14 degrees of freedom. Then, Bonferroni adjustment points to eight 
rejections. Also applying the FDR controlling BH procedure on the raw p-values, they came up with the same 
eight genes identiﬁed as differentially expressed in the original analysis. 
 
4. Conclusions and Recommendations  
4.1 Conclusions 
Lasso method selects four important SNPs which appear to be associated to the Oligoclonal Bands subpopulation 
of multiple sclerosis patients. These are most frequently selected SNPs which are the one which we selected in the 
end. 
We also ﬁtted the model to our dataset which contains those selected SNPs by our method (See Equation 9). 
From results of analysis I, we found out that none of the interaction variables are selected and the ﬁndings further 
suggest four SNPs in- dependently determine the status of Oligoclonal Bands subpopulation of multiple sclerosis 
patients. The results from analysis II, showed that 38 important SNPs from 923 SNPs in the genomic TSAD region 
that are associated with Oligoclonal Bands (OCBs) subpopulation of multiple sclerosis patients. Result for 
Bonferroni correction showed none of SNPs are signiﬁcant at 0.05 levels. The results from analysis for FDR at 
0.05 signiﬁcant level showed 38 SNPs are all important to determine Oligoclonal Bands (OCBs) subpopulation of 
multiple sclerosis patients. Finally, results from analysis II showed seven important SNP-SNP interactions which 
determine Oligoclonal Bands (OCBs) subpopulation of multiple sclerosis patients, based on our study of the 
Norwegian cohort. Then, we collected all SNPs (See Table 8) (with the SNPs where they are located) which have 
been selected by any of the methods that we used (various hypothesis testing and regressions). These are the list 
of SNPs that we think should be studied further and validated on a new data set. Of particular importance are the 
seven SNP-SNP interactions which we found. It is the ﬁrst time a SNP-SNP study has been performed on these 
data, and the ﬁnding will be communicated to the Norwegian molecular biologists to be followed up (See Table7). 
 
4.2 Recommendations 
The ﬁndings of this study have important implications to help biologists, healthy organizations, researchers and 
scientists to deal on disease prevalence and progression such that, genes are important factors for cause of MS. As 
the new study in this area, this may motivate interested groups and professionals to be aware of the disease, and it 
perhaps initiate them to their own contributions in the same area of research. Since Lasso selects SNPs which are 
best to perform classiﬁcation (outcome) of a new patient. These are SNPs which each carry additional independent 
information on the classiﬁcation. This means that two covariates which are both very strongly associated with the 
outcome and are also highly correlated with each other, will not be both selected by the Lasso, because only one 
covariate contributes to the best classiﬁcation, the other carries the same information. The Bonferroni and FDR 
correction do not look to the correlation of the SNPs, but only on how many tests we performed, and reduce the 
signiﬁcance level so that we make less false positives mistakes. Therefore, we have generated a series of biological 
hypothesis, supported by our stringent data analysis, which now need to be conﬁrmed on a new population. If this 
will be the case, then it is possible to imagine that ﬁnding these SNPs in MS patients, will allow a better therapy. 
Therefore, our results need to be further validated. 
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